LIMAA Technologies key facts
- Developer of an automated tissue-preserving 3D histopathology platform designed to help pathologists increase their sample throughput from tissue preparation to analysis.
- Notable investors include Nvidia, Bundesministerium für Wirtschaft und Klimaschutz, Ascenion, Aescuvest, BIH Digital Health Accelerator.
- Status: Privately Held (backing).
Who backs LIMAA Technologies
5- ·Watch LIMAA Technologies: the Monday email on marks, rounds and moves
LIMAA Technologies funding rounds
No funding rounds for LIMAA Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
LIMAA Technologies investors
5 investors are on record for LIMAA Technologies, including Nvidia, Bundesministerium für Wirtschaft und Klimaschutz, Ascenion and Aescuvest.
About LIMAA Technologies
Developer of an automated tissue-preserving 3D histopathology platform designed to help pathologists increase their sample throughput from tissue preparation to analysis. The company's platform allows clients to analyze entire tissue biospecimens without embedding or slicing and visualization of tissue samples including downstream genomic analysis, enabling pathologists to evaluate guideline-specific multiplexed biomarker staining of tissue samples with cellular 3D spatial resolution in a clinically feasible time.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Employees
- 6
- Website
- limaa-technologies.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
LIMAA Technologies doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.